🇺🇸 Lithium Carbonate Capsule in United States

12 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 23 April 2025 – 23 April 2026
• Total reports: 12

Most-reported reactions

1. Drug Abuse — 3 reports (25%)
2. Bradykinesia — 1 report (8.33%)
3. Bradyphrenia — 1 report (8.33%)
4. Coma — 1 report (8.33%)
5. Confusional State — 1 report (8.33%)
6. Drug Ineffective — 1 report (8.33%)
7. Extrapyramidal Disorder — 1 report (8.33%)
8. Hyperthyroidism — 1 report (8.33%)
9. Hyporeflexia — 1 report (8.33%)
10. Intentional Self-Injury — 1 report (8.33%)

Source database →

Frequently asked questions

Is Lithium Carbonate Capsule approved in United States?

Lithium Carbonate Capsule does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Lithium Carbonate Capsule in United States?

University of Milan is the originator. The local marketing authorisation holder may differ — check the official source linked above.